A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

December 15, 2026

Study Completion Date

November 1, 2028

Conditions
Obesity
Interventions
DRUG

CagriSema (Cagrilintide B and Semaglutide I)

CagriSema (Cagrilintide B and Semaglutide I) will be administered subcutaneously using DV3384 pen-injector.

DRUG

Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Placebo matched to Cagrilintide B and placebo matched to Semaglutide I will be administered subcutaneously using DV3384 pen-injector.

Trial Locations (45)

14224

Southgate Medical Group, LLP, West Seneca

14787

Great Lakes Medical Research, Westfield

22206

Washington Cntr Weight Mgmt, Arlington

23606

Health Res of Hampton Roads, Newport News

27405

Medication Mgmnt, LLC_Grnsboro, Greensboro

27408

PharmQuest Life Sciences LLC, Greensboro

27514

University of North Carolina, Chapel Hill

27609

Accellacare_NC, Raleigh

28401

Accellacare, Wilmington

28625

Piedmont Healthcare/Research, Statesville

29303

Spartanburg Medical Research, Spartanburg

29405

Coastal Carolina Res Ctr, North Charleston

30076

Endocrine Research Solutions, Roswell

30094

Hope Clin Res & Wellness, Conyers

32003

Northeast Research Institute, Fleming Island

32216

Jacksonville Ctr For Clin Res, Jacksonville

32765

Oviedo Medical Research, LLC, Oviedo

32825

Florida Inst For Clin Res LLC, Orlando

33024

Cnt for Diab,Obes, and Metab, Pembroke Pines

33027

South Broward Research LLC, Miramar

37203

Clinical Research Associates, Nashville

37660

Holston Medical Group, Kingsport

46260

Midwest Inst For Clin Res, Indianapolis

49620

Northern Pines Hlth Ctr, PC, Buckley

50266

Iowa Diab & Endo Res Center, West Des Moines

59701

Mercury Str Med Grp, PLLC, Butte

60077

Endeavor Health, Skokie

Evanston Premier Hlthcr Res, Skokie

60640

Great Lakes Clinical Trials, Chicago

63128

Amicis Centers of Clinical Research, St Louis

63303

StudyMetrix Research LLC, City of Saint Peters

73072

Lynn Institute of Norman, Norman

75230

Velocity Clin Res, Dallas, Dallas

76550

Radiance Clinical Research, Lampasas

77079

PlanIt Research, PLLC, Houston

78154

Northeast Clinical Research of San Antonio, Schertz

79106

Amarillo Med Spec LLP, Amarillo

92111

Linda Vista Health Care Ctr, San Diego

92627

FDRC, Costa Mesa

94598

Diablo Clinical Research, Inc., Walnut Creek

98057

Rainier Clin Res Ctr Inc, Renton

44281-9236

New Venture Medical Research, Wadsworth

02864

Clinical Res Collaborative, Cumberland

29681-1538

Hillcrest Clinical Research, Simpsonville

22601-3834

Selma Medical Associates, Winchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT07011667 - A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term | Biotech Hunter | Biotech Hunter